{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Prelude Therapeutics Incorporated"},"Symbol":{"label":"Symbol","value":"PRLD"},"Address":{"label":"Address","value":"200 POWDER MILL ROAD, WILMINGTON, Delaware, 19803, United States"},"Phone":{"label":"Phone","value":"+1 302 467-1280"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need."},"CompanyUrl":{"label":"Company Url","value":"https://www.preludetx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Aimee Crombie","title":"Senior VP, Head-Strategic Planning & Operations"},{"name":"Jane E. Huang","title":"President & Chief Medical Officer"},{"name":"Krishna Vaddi","title":"Chief Executive Officer & Director"},{"name":"Madhu Pudipeddi","title":"Vice President-Technical Operations"},{"name":"Peggy A. Scherle","title":"Chief Scientific Officer"},{"name":"Wan-Jen Hong","title":"Senior Vice President-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}